PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

In triple-negative breast cancer, the PIM1 kinase is highly expressed, acts to promote tumor cell survival and growth, and increases MYC transcriptional activity.